483
Novartis Pharmaceuticals CorporationNovartis Pharmaceuticals Corporation – FDA 483, Dec 14, 2018
Record Details
Novartis Pharmaceuticals Corp. in East Hanover, NJ, was cited for significant failures in monitoring a clinical study. The firm failed to ensure the study was conducted according to the protocol and investigational plan, leading to numerous instances of site personnel and raters having inappropriate access to unblinded study subject information. Monitors also failed to identify and correct these critical database access errors over an extended period.
View Company Profile
ID · fbb8db5f-8a5a-4601-9915-315db47dee65
Other documents for Novartis Pharmaceuticals Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.